Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance - PubMed (original) (raw)
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
C J de Souza et al. Diabetes. 2001 Aug.
Abstract
Obesity and dysfunctional energy partitioning can lead to the development of insulin resistance and type 2 diabetes. The antidiabetic thiazolidinediones shift the energy balance toward storage, leading to an increase in whole-body adiposity. These studies examine the effects of pioglitazone (Pio) on adipose tissue physiology, accumulation, and distribution in female Zucker (fa/fa) rats. Pio treatment (up to 28 days) decreased the insulin-resistant and hyperlipidemic states and increased food consumption and whole-body adiposity. Magnetic resonance imaging (MRI) analysis and weights of fat pads demonstrated that the increase in adiposity was not only limited to the major fat depots but also to fat deposition throughout the body. Adipocyte sizing profiles, fat pad histology, and DNA content show that Pio treatment increased the number of small adipocytes because of both the appearance of new adipocytes and the shrinkage and/or disappearance of existing mature adipocytes. The remodeling was time dependent, with new small adipocytes appearing in clusters throughout the fat pad, and accompanied by a three- to fourfold increase in citrate synthase and fatty acid synthase activity. The appearance of new fat cells and the increase in fat mass were depot specific, with a rank order of responsiveness of ovarian > retroperitoneal > subcutaneous. This differential depot effect resulted in a redistribution of the fat mass in the abdominal region such that there was an increase in the visceral:subcutaneous ratio, as confirmed by MRI analysis. Although the increased adiposity is paradoxical to an improvement in insulin sensitivity, the quantitative increase of adipose mass should be viewed in context of the qualitative changes in adipose tissue, including the remodeling of adipocytes to a smaller size with higher lipid storage potential. This shift in energy balance is likely to result in lower circulating free fatty acid levels, ultimately improving insulin sensitivity and the metabolic state.
Similar articles
- Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243.
Burkey BF, Dong M, Gagen K, Eckhardt M, Dragonas N, Chen W, Grosenstein P, Argentieri G, de Souza CJ. Burkey BF, et al. Metabolism. 2000 Oct;49(10):1301-8. doi: 10.1053/meta.2000.9524. Metabolism. 2000. PMID: 11079820 - Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Okuno A, et al. J Clin Invest. 1998 Mar 15;101(6):1354-61. doi: 10.1172/JCI1235. J Clin Invest. 1998. PMID: 9502777 Free PMC article. - Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: effects of pioglitazone.
Kurowski TG, Saha AK, Cunningham BA, Holbert RI, Colca JR, Corkey BE, Ruderman NB. Kurowski TG, et al. Metabolism. 1996 Apr;45(4):519-25. doi: 10.1016/s0026-0495(96)90230-9. Metabolism. 1996. PMID: 8609842 - Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
Smith SA. Smith SA. Biochimie. 2003 Dec;85(12):1219-30. doi: 10.1016/j.biochi.2003.10.010. Biochimie. 2003. PMID: 14739074 Review. - [Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].
Dubois M, Vantyghem MC, Schoonjans K, Pattou F. Dubois M, et al. Ann Endocrinol (Paris). 2002 Dec;63(6 Pt 1):511-23. Ann Endocrinol (Paris). 2002. PMID: 12527853 Review. French.
Cited by
- Pioglitazone Antagonized the Effects of Advanced Glycation End Products on Achilles Tendon Healing and Improved the Recovery of Tendon Biomechanical Properties.
Jia G, Jia X, Yang J, Shi T, Qiang M, Chen Y. Jia G, et al. Cell Mol Bioeng. 2024 Apr 2;17(3):219-228. doi: 10.1007/s12195-024-00800-7. eCollection 2024 Jun. Cell Mol Bioeng. 2024. PMID: 39050514 - Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, "futile" fatty acid cycling, and FADH2 oxidation.
Abrosimov R, Baeken MW, Hauf S, Wittig I, Hajieva P, Perrone CE, Moosmann B. Abrosimov R, et al. Geroscience. 2024 Aug;46(4):3635-3658. doi: 10.1007/s11357-023-01059-y. Epub 2024 Jan 25. Geroscience. 2024. PMID: 38267672 Free PMC article. - Depot-Dependent Impact of Time-Restricted Feeding on Adipose Tissue Metabolism in High Fat Diet-Induced Obese Male Mice.
Bushman T, Lin TY, Chen X. Bushman T, et al. Nutrients. 2023 Jan 3;15(1):238. doi: 10.3390/nu15010238. Nutrients. 2023. PMID: 36615895 Free PMC article. - Regulatory Effects and Mechanism of Action of Green Tea Polyphenols on Osteogenesis and Adipogenesis in Human Adipose Tissue-Derived Stem Cells.
Lao W, Zhao Y, Tan Y, Johnson M, Li Y, Xiao L, Cheng J, Lin Y, Qu X. Lao W, et al. Curr Issues Mol Biol. 2022 Nov 30;44(12):6046-6058. doi: 10.3390/cimb44120412. Curr Issues Mol Biol. 2022. PMID: 36547073 Free PMC article. - From an Apple to a Pear: Moving Fat around for Reversing Insulin Resistance.
Alser M, Elrayess MA. Alser M, et al. Int J Environ Res Public Health. 2022 Oct 31;19(21):14251. doi: 10.3390/ijerph192114251. Int J Environ Res Public Health. 2022. PMID: 36361131 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical